Jiri Masopust
Charles University in Prague
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jiri Masopust.
Psychiatry and Clinical Neurosciences | 2009
Radovan Maly; Jiri Masopust; Ladislav Hosák; Aleš Urban
Aims: Psychiatric disorders and treatment with conventional antipsychotic medications have been associated with venous thromboembolism, but only a few data on recent antipsychotics such as olanzapine are available.
The Cerebellum | 2011
Jan Kremlacek; Martin Vališ; Jiri Masopust; Aleš Urban; Alena Zumrova; Radomír Taláb; Miroslav Kuba; Zuzana Kubová; J. Langrová
Reports of visual functional impairment in spinocerebellar ataxia type 2 (SCA2) have been studied previously using pattern reversal visually evoked potentials (VEPs) with contradictory results. To provide additional evidence to this area, visual functions were studied using VEPs and event-related potentials (ERPs) in a group of ten patients with genetically verified SCA2. The electrophysiological examination included pattern reversal and motion-onset VEPs as well as visually driven oddball ERPs with an evaluation of a target and a pre-attentive response. In six patients, we found abnormal visual/cognitive processing that differed from normal values in latency, but not in the amplitude of the dominant VEP/ERP peaks. Among the VEPs/ERPs used, the motion-onset VEPs exhibited the highest sensitivity and showed a strong Spearman correlation to SCA2 duration (from r = 0.82 to r = 0.90, p < 0.001) and clinical state assessed by Brief Ataxia Rating Scale (from r = 0.71 (p = 0.022) to r = 0.80 (p < 0.001)). None of the VEP/ERP latencies showed a correlation to the triplet repeats of the SCA2 gene. In three patients, we did not find any visual/cognitive pathology, and one subject showed only a single subtle prolongation of the VEP peak. The observed visual/cognitive deficit was related to the subjects’ clinical state and the illness duration, but no relationship to the genetic marker of SCA2 was found. From the VEP/ERP types used, the motion-onset VEPs seems to be the most promising candidate for clinical state monitoring rather than a tool for early diagnostic use.
Psychiatria Danubina | 2012
Dita Protopopová; Jiri Masopust; Radovan Maly; Martin Vališ; Jan Bazant
Neuro endocrinology letters | 2008
Martin Vališ; Radomír Taláb; Pavel Štourač; Ctirad Andrys; Jiri Masopust
Neuro endocrinology letters | 2008
Jiri Masopust; Tůma I; Libiger J
Neuro endocrinology letters | 2011
Martin Vališ; Jiri Masopust; Bažant J; Ríhová Z; Kalnická D; Urban A; Zumrová A; Hort J
Neuro endocrinology letters | 2007
Urban A; Jiri Masopust; Malý R; Ladislav Hosák; Kalnická D
Neuro endocrinology letters | 2008
Katerina Konupcikova; Jiri Masopust; Martin Vališ; Jiri Horacek
Neurotoxicity Research | 2017
Martin Vališ; Jiri Masopust; Oldrich Vysata; Jakub Hort; Rafael Dolezal; Jiri Tomek; Jan Misik; Kamil Kuca; Jana Zdarova Karasova
Neuro endocrinology letters | 2009
Jiri Masopust; Urban A; Martin Vališ; Malý R; Tůma I; Ladislav Hosák